ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
-0.68%
US Tech 100
18,590.00
-0.02%
S&P 500
5,351.52
-0.17%
US Dollar vs CAD
1.37739
0.09%
Bitcoin
66,783.83
-3.92%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Structure Therapeutics Inc (GPCR)

  7. Structure Therapeutics Inc (GPCR) News

GPCR

Structure Therapeutics (GPCR)

Structure Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GPCR
DateTimeSourceHeadlineSymbolCompany
06/07/20243:05PMGlobeNewswire Inc.Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary SharesNASDAQ:GPCRStructure Therapeutics Inc
06/06/20243:17PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:GPCRStructure Therapeutics Inc
06/05/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GPCRStructure Therapeutics Inc
06/05/20246:53PMGlobeNewswire Inc.Structure Therapeutics Announces Pricing of Upsized $476 Million Public OfferingNASDAQ:GPCRStructure Therapeutics Inc
06/05/20246:43PMEdgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:GPCRStructure Therapeutics Inc
06/05/20246:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GPCRStructure Therapeutics Inc
06/03/20243:59PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
06/03/20243:58PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GPCRStructure Therapeutics Inc
06/03/20243:09PMGlobeNewswire Inc.Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded WarrantsNASDAQ:GPCRStructure Therapeutics Inc
06/03/20243:02PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GPCRStructure Therapeutics Inc
06/03/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
06/03/20246:30AMGlobeNewswire Inc.Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290NASDAQ:GPCRStructure Therapeutics Inc
05/09/20243:56PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
05/09/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
05/09/20243:05PMGlobeNewswire Inc.Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
03/08/20243:19PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GPCRStructure Therapeutics Inc
03/08/20243:05PMGlobeNewswire Inc.Structure Therapeutics to Present at Leerink Partners Global Biopharma ConferenceNASDAQ:GPCRStructure Therapeutics Inc
03/08/20248:19AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GPCRStructure Therapeutics Inc
03/08/20247:43AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
03/08/20247:30AMGlobeNewswire Inc.Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
12/18/20237:28AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
12/18/20236:30AMGlobeNewswire Inc.Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical StudyNASDAQ:GPCRStructure Therapeutics Inc
11/29/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GPCRStructure Therapeutics Inc
11/17/20234:25PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GPCRStructure Therapeutics Inc
11/17/20233:55PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
11/17/20233:51PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
11/16/20234:13PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
11/14/20233:10PMGlobeNewswire Inc.Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
09/29/20236:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
09/29/20236:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GPCR

Your Recent History

USOTC
NSAV
Net Savings Link (PK)
USOTC
PSRU
Valiant Eagle (PK)
AMEX
SPY
SPDR S&P 500
USOTC
KEGS
1812 Brewing (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
HQGE
HQ Global Education (CE)
NASDAQ
AGBA
AGBA
USOTC
AXXA
Exxe (PK)
NASDAQ
RVNC
Revance Therapeutics
USOTC
BLEG
Branded Legacy (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
AHRO
Authentic (CE)
USOTC
BIEL
Bioelectronics (PK)
USOTC
SAPX
Seven Arts Entertainment (PK)
NASDAQ
COOP
Mr Cooper
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved